Liability of the Voltage-Gated Sodium Channel Gene SCN2A R19K Polymorphism to Oxaliplatin-Induced Peripheral Neuropathy

Publisher： Karger

E-ISSN： 1423-0232|77|3-4|254-256

ISSN： 0030-2414

Source： Oncology, Vol.77, Iss.3-4, 2009-09, pp. : 254-256

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Voltage‐gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin‐induced peripheral neurotoxicity: Results from a prospective multicenter study

By  

CANCER, Vol. 119, Iss. 19, 2013-10 ,pp. : 3570-3577

John Wiley & Sons Inc

Access to resources Recommend Favorite

Shaker‐related voltage‐gated K+ channel expression and vasomotor function in human coronary resistance arteries

By  

MICROCIRCULATION (ELECTRONIC), Vol. 25, Iss. 1, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

PKC/MEK inhibitors suppress oxaliplatin‐induced neuropathy and potentiate the antitumor effects

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 1, 2015-07 ,pp. : 243-250

John Wiley & Sons Inc

Access to resources Recommend Favorite

Calcium and Magnesium Infusions for the Prevention of Oxaliplatin-Induced Peripheral Neurotoxicity: A Systematic Review

By  

Oncology, Vol. 90, Iss. 6, 2016-05 ,pp. : 299-306

Karger

Access to resources Recommend Favorite

Transcriptional regulation of voltage‐gated Ca2+ channels

By  

ACTA PHYSIOLOGICA (ELECTRONIC), Vol. 222, Iss. 1, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite